dinitrobenzene sulfonic acid | 112600-28-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: dinitrobenzene sulfonic acid
• 英文别名: DNBS；2,3-dinitro-benzenesulfonic acid；2,3-Dinitro-benzolsulfonsaeure；2,3-dinitrobenzenesulfonic acid
• CAS: 112600-28-9
• 化学式: C₆H₄N₂O₇S
• 分子量: 248.173
• InChiKey: IORISFYTXJVNFE-UHFFFAOYSA-N

物化性质

• 密度：
  1.826±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  154
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  sodium O-ethyl dithiocarbonate 、 alkaline earth salt of/the/ methylsulfuric acid 在 水 作用下， 生成 dinitrobenzene sulfonic acid
  参考文献：
  名称：

  Kiprianow; Tolmatschew, Zhurnal Obshchei Khimii, 1957, vol. 27, p. 486,491; engl. Ausg. S. 553, 557

  摘要：

  DOI：

文献信息

• [EN] NEW TRPA1 ANTAGONISTS<br/>[FR] NOUVEAUX ANTAGONISTES DE TRPA1
  申请人：ALMIRALL SA

  公开号：WO2017060488A1

  公开（公告）日：2017-04-13

  The present invention relates to compounds of Formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by TRPA1 channel inhibition or antagonism.

  本发明涉及式(I)的化合物，以及制备这种化合物的方法，以及它们在治疗通过TRPA1通道抑制或拮抗可改善的病理状况或疾病中的用途。
• [EN] N-ACYLETHANOLAMINE HYDROLYZING ACID AMIDASE (NAAA) INHIBITORS AND THEIR USE THEREOF<br/>[FR] INHIBITEURS D'AMIDASE ACIDE (NAAA) HYDROLYSANT LA N-ACYLÉTHANOLAMINE ET LEUR UTILISATION
  申请人：UNIV NORTHEASTERN

  公开号：WO2015179190A1

  公开（公告）日：2015-11-26

  A compound is represented as Formula I, a tautomer thereof, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. Compounds of Formula I are inhibitors of N-acylethanolamine hydrolyzing acid amidase (NAAA). The present technology is directed to compounds, compositions, and methods to inhibit N-acylethanolamine hydrolyzing acid amidase and to treat N-acylethanolamine hydrolyzing acid amidase mediated conditions in a subject.

  一种化合物被表示为化学式I，其互变异构体、立体异构体或其药学上可接受的盐。化学式I的化合物是N-酰乙醇胺水解酸酰胺酶（NAAA）的抑制剂。本技术涉及到抑制N-酰乙醇胺水解酸酰胺酶的化合物、组合物和方法，以及治疗受试者中的N-酰乙醇胺水解酸酰胺酶介导的疾病。
• [EN] HALOGENATED S-(PERFLUOROALKYL) DIBENZOTHIOPHENIUM SALT AND ITS PRODUCTION METHODS<br/>[FR] SEL DE DIBENZOTHIOPHÉNIUM S-(PERFLUOROALKYL) HALOGÉNÉ ET SES PROCÉDÉS DE PRODUCTION
  申请人：ZHEJIANG JIUZHOU PHARM CO LTD

  公开号：WO2016107578A1

  公开（公告）日：2016-07-07

  Halogenated S-(perfluoroalkyl) dibenzothiophenium salt represented by the following general formula (I). This compound is a new, reactive, and industrially useful reagent for perfluoroalkylating organic compounds. The reagent can be prepared by a one-pot process or a two-step reaction process from a halogenated biphenyl and easily isolated by a filtration method. In addition, the halogenated biphenyl can be recovered by desulfurization from a halogenated dibenzothiophene obtained as a side-product by the usage of the reagent.

  以下是通用公式（I）所代表的卤代S-(全氟烷基)二苯并噻吩盐。该化合物是一种新的、反应活泼且在工业上有用的全氟烷基化有机化合物的试剂。该试剂可以通过一锅法或两步反应法从卤代联苯制备，并且可以通过过滤方法轻松地分离。此外，通过使用该试剂产生的副产物——卤代二苯并噻吩，可以通过脱硫来回收卤代联苯。
• [EN] "INHIBITORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, COMPOSITIONS, PRODUCTS AND USES THEREOF"<br/>[FR] "INHIBITEURS DE NICOTINAMIDE PHOSPHORIBOSYLTRANSFÉRASE, COMPOSITIONS, PRODUITS ET LEURS UTILISATIONS"
  申请人：UNIVERSIT DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO

  公开号：WO2014178001A1

  公开（公告）日：2014-11-06

  Compounds of formula (I): able to inhibit nicotinamide phosphoribosyltransferase. The disclosure also relates to the use of compounds of formula (I) for treatment of pathological conditions in which NAMPT inhibition might be beneficial, such as acute and chronic inflammation, cancer and metabolic disorders.

  化学式（I）的化合物：能够抑制烟酰胺磷酸核糖转移酶。该公开还涉及使用化学式（I）的化合物来治疗可能受益于NAMPT抑制的病理条件，如急性和慢性炎症、癌症和代谢紊乱。
• [EN] AMIDE COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS<br/>[FR] COMPOSÉS AMIDES UTILISÉS EN TANT QU'INHIBITEURS DE LA TRYPTOPHANE HYDROXYLASE
  申请人：KAROS PHARMACEUTICALS INC

  公开号：WO2016109501A1

  公开（公告）日：2016-07-07

  The present invention is directed to amide compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment or prevention of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, fibrotic, and low bone mass diseases, as well as cancer.

  本发明涉及酰胺化合物，这些化合物是色氨酸羟化酶（TPH）的抑制剂，特别是异构体1（TPH1），可用于治疗或预防与外周血清素相关的疾病或紊乱，例如，胃肠道、心血管、肺部、炎症、代谢、纤维化和低骨密度疾病，以及癌症。